Omega Therapeutics (OMGA)

Omega Therapeutics Stock Analysis & Ratings

OMGA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.49 - $31.41
Previous Close$3.17
Average Volume (3M)144.40K
Market Cap$151.68M
P/E Ratio-2.0
Next EarningsSep 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3
EPS (TTM)-1.57

Omega Therapeutics News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Omega Therapeutics’s price range in the past 12 months?
Omega Therapeutics lowest stock price was $2.49 and its highest was $31.41 in the past 12 months.
    What is Omega Therapeutics’s market cap?
    Omega Therapeutics’s market cap is $151.68M.
      What is Omega Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Omega Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      When is Omega Therapeutics’s upcoming earnings report date?
      Omega Therapeutics’s upcoming earnings report date is Sep 09, 2022 which is in 114 days.
        How were Omega Therapeutics’s earnings last quarter?
        Omega Therapeutics released its earnings results on May 04, 2022. The company reported -$0.42 earnings per share for the quarter, beating the consensus estimate of -$0.568 by $0.148.
          Is Omega Therapeutics overvalued?
          According to Wall Street analysts Omega Therapeutics’s price is currently Overvalued.
            Does Omega Therapeutics pay dividends?
            Omega Therapeutics does not currently pay dividends.
            What is Omega Therapeutics’s EPS estimate?
            Omega Therapeutics’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Omega Therapeutics have?
            Omega Therapeutics has 47,850,000 shares outstanding.
              What happened to Omega Therapeutics’s price movement after its last earnings report?
              Omega Therapeutics reported an EPS of -$0.42 in its last earnings report, beating expectations of -$0.568. Following the earnings report the stock price went down -1.511%.
                Which hedge fund is a major shareholder of Omega Therapeutics?
                Among the largest hedge funds holding Omega Therapeutics’s share is Flagship Pioneering Inc.. It holds Omega Therapeutics’s shares valued at 162M.


                  Omega Therapeutics Stock Analysis

                  Smart Score
                  Price Target
                  No data currently available
                  The Omega Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Omega Therapeutics

                  Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.

                  Similar Stocks
                  No data currently available

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis